101
|
Blain A, Greally E, MacGowan G, Laval S, Blamire A, Gillender K, Lochmüller H, Bushby K, Straub V. P18 Beta-blocker/ACE-inhibitor combination treatment in mdx mice. Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70026-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
102
|
Machado P, Hudson J, Miller A, Morrow J, Parton M, Bushby K, Hanna M. P82 Myofibrillar myopathies (MFM), valosin containing protein (VCP) and glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) genes' mutations are not associated with sporadic inclusion body myositis (sIBM). Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70090-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
103
|
Henderson M, Hudson J, Marsh J, Charlton R, Straub V, Lochmüller H, Bushby K, Vissing J, Barresi R. P70 A single in-frame deletion in the CAPN3 gene is linked to muscular dystrophy with a dominant pattern of inheritance. Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70078-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
104
|
Hicks D, Martoni E, Straub V, Lochmüller H, Laval S, Bushby K. P79 Identification of novel variants in patients with non-collagen VI Bethlem myopathy by the emerging technology of exomic sequencing. Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70087-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
105
|
De Waele L, Henderson M, Hudson J, Horrocks I, Longman C, Bushby K, Barresi R. P77 Autosomal recessive desminopathy with desmin-null mutations presenting in childhood. Neuromuscul Disord 2012. [DOI: 10.1016/s0960-8966(12)70085-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
106
|
Klein A, Lillis S, Oprea I, Scoto M, Robb S, Manzur A, Straub V, Roper H, Jeannet P, Kingston H, Jensen U, Wraige E, Trump N, Rakowicz W, M. Roberts, Longman C, Lochmuller H, Bushby K, Hughes M, Abbs S, Jungbluth H, Muntoni F. P3.41. Clinical and genetic findings in a large cohort of patients with congenital myopathies due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
107
|
Finkel R, Wong B, Bushby K, Voit T, Morsy M, Elfring G, Barth J, Peltz S. P4.10 The relationship of ataluren plasma concentration and response across clinical studies in nonsense mutation dystrophinopathy. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.975] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
108
|
Blain A, Greally E, Laval S, Blamire A, Lochmuller H, Bushby K, MacGowan G, Straub V. P4.17 Manganese enhanced MRI (MEMRI) as an outcome measure for cardiac function in the mdx mouse. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
109
|
Ritso M, Dick E, Reza M, Laval S, Bushby K, Straub V, Denning C, Lochmuller H. P4.36 Develoment of pluripotent stem celss as vectors for viral gene therapy. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.1001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
110
|
Treves S, Jeannet P, Vukcevic M, Levano S, Girard T, Urwyler A, Fischer D, Voit T, Jungbluth H, Lillis S, Muntoni F, Quinlivan R, Sarkozy A, Bushby K, Zorzato F. I-13
Muscle ryanodine receptor in congenital
myopathies and channelopathies. ACTA MYOLOGICA 2011. [PMCID: PMC3235834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
111
|
Mercuri E, Bushby K, McDonald C, Goemans N, Muntoni F, Darras B, Elfring G, Barth J, Reha A, Peltz S. P1.33 Disease progression observed in clinical outcome measures in placebo-treated patients with nonsense mutation dystrophinopathy. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.793] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
112
|
Willis T, Hollingsworth K, Sveen M, Morrow J, Vandenheede J, Strojkovic T, Eagle M, Mayhew A, Bushby K, Lochmuller H, Hanna M, Vissing J, Straub V. P2.22 Quantitative MRI in LGMD2I; a longitudinal study. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
113
|
Gramsch K, Vry J, Rahbek J, Steffensen B, Bushby K, Lochmüller H, Rodger S, Kirschner J. P4.64 Monitoring care practices for Duchenne Muscular Dystrophy – the CARE-NMD project. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.1029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
114
|
Scoto M, Cirak S, Mein R, Feng L, Manzur AY, Robb S, Childs AM, Quinlivan RM, Roper H, Jones DH, Longman C, Chow G, Pane M, Main M, Hanna MG, Bushby K, Sewry C, Abbs S, Mercuri E, Muntoni F. SEPN1-related myopathies: clinical course in a large cohort of patients. Neurology 2011; 76:2073-8. [PMID: 21670436 DOI: 10.1212/wnl.0b013e31821f467c] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To assess the clinical course and genotype-phenotype correlations in patients with selenoprotein-related myopathy (SEPN1-RM) due to selenoprotein N1 gene (SEPN1) mutations for a retrospective cross-sectional study. METHODS Forty-one patients aged 1-60 years were included. Clinical data including scoliosis, respiratory function, and growth measurements were collected by case note review. RESULTS Mean age at onset was 2.7 years, ranging from birth to the second decade of life. All but 2 remained independently ambulant: one lost ambulation at age 5 years and another in his late 50s. The mean age of starting nocturnal noninvasive ventilation (NIV) was 13.9 years. One child required full-time NIV at the age of 1 year while in 2 cases NIV was started at 33 years. Two patients died from respiratory failure at the age of 10 and 22 years, respectively. The mean age at scoliosis onset was 10 years, in most cases preceded by rigidity of the spine. Fourteen patients had successful spinal surgery (mean age 13.9 years). Twenty-one were underweight; however, overt feeding difficulties were not a feature. CONCLUSIONS This study describes the largest population affected by SEPN1-RM reported so far. Our findings show that the spectrum of severity is wider than previously reported. Respiratory insufficiency generally develops by 14 years but may occur as early as in infancy or not until the fourth decade. Motor abilities remain essentially static over time even in patients with early presentation. Most adult patients remain ambulant and fully employed.
Collapse
|
115
|
Willis T, Lochmuller H, Bushby K, Straub V. Dried Blood Spot Testing—The Newcastle Experience Over a Twelve Month Period. Clin Ther 2011. [DOI: 10.1016/j.clinthera.2011.05.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
116
|
Treves S, Vukcevic M, Jeannet PY, Levano S, Girard T, Urwyler A, Fischer D, Voit T, Jungbluth H, Lillis S, Muntoni F, Quinlivan R, Sarkozy A, Bushby K, Zorzato F. Enhanced excitation-coupled Ca2+ entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease. Hum Mol Genet 2011. [DOI: 10.1093/hmg/ddr083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
117
|
Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, Hollingsworth KG, Hunt D, Jungbluth H, Roper HP, Quinlivan RM, Gosalakkal JA, Jayawant S, Nadeau A, Hughes-Carre L, Manzur AY, Mercuri E, Morgan JE, Straub V, Bushby K, Sewry C, Rutherford M, Muntoni F. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011; 76:346-53. [PMID: 21263136 DOI: 10.1212/wnl.0b013e318208811f] [Citation(s) in RCA: 114] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being piloted. Most of these trials have as an endpoint the restoration of dystrophin in muscle fibers, hence requiring sufficiently well-preserved muscle of recruited patients. The choice of the muscles to be studied and the role of noninvasive methods to assess muscle preservation therefore require further evaluation. METHODS We studied the degree of muscle involvement in the lower leg muscles of 34 patients with DMD >8 years, using muscle MRI. In a subgroup of 15 patients we correlated the muscle MRI findings with the histology of open extensor digitorum brevis (EDB) muscle biopsies. Muscle MRI involvement was assigned using a scale 0-4 (normal-severe). RESULTS In all patients we documented a gradient of involvement of the lower leg muscles: the posterior compartment (gastrocnemius > soleus) was most severely affected; the anterior compartment (tibialis anterior/posterior, popliteus, extensor digitorum longus) least affected. Muscle MRI showed EDB involvement that correlated with the patient's age (p = 0.055). We show a correlation between the MRI and EDB histopathologic changes, with MRI 3-4 grades associated with a more severe fibro-adipose tissue replacement. The EDB was sufficiently preserved for bulk and signal intensity in 18/22 wheelchair users aged 10-16.6 years. CONCLUSION This study provides a detailed correlation between muscle histology and MRI changes in DMD and demonstrates the value of this imaging technique as a reliable tool for the selection of muscles in patients recruited into clinical trials.
Collapse
|
118
|
Reza M, Laval S, Morgan J, Muntoni F, Bushby K, Straub V, Lochmüller H. P08 Optimal dystrophin mini-construct for gene delivery to skeletal muscle. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70027-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
119
|
Scoto M, Cirak S, Mein R, Feng L, Manzur A, Robb S, Childs AM, Quinlivan R, Roper H, Hilton-Jones D, Longman C, Chow G, Pane M, Main M, Hanna M, Bushby K, Sewry C, Abbs S, Mercuri E, Muntoni F. P67 SEPN1 related myopathies: Clinical course in a large cohort of patients. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70086-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
120
|
Müller J, Senderek J, Dusl M, Guergueltcheva V, Laval S, Bushby K, Straub V, Beeson D, Abicht A, Lochmüller H. P26 Pyridostigmine-responsive limb-girdle congenital myasthenic syndrome with frequent tubular aggregates. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70045-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
121
|
Sarkozy A, Hicks P, Miller J, Walter M, Reilich P, Radunovic A, Vaidya S, Lochmüller H, Bushby K, Straub V. P75 Muscle MRI findings in LGMD2L. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70094-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
122
|
Wood A, Jepson C, Laval S, Bushby K, Lochmüller H, Barresi R, Müller J, Straub V. P19 Generating stable FKRP mutant zebrafish lines with zinc finger nucleases. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70038-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
123
|
Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Garralda M, Wells D, Dickson G, Wood M, Wilton S, Straub V, Shrewsbury S, Sewry C, Morgan J, Bushby K, Muntoni F. P03 Exon skipping and dystrophin restoration in Duchenne muscular dystrophy patients after systemic phosphorodiamidate morpholino oligomer treatment. Neuromuscul Disord 2011. [DOI: 10.1016/s0960-8966(11)70022-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
124
|
Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M, Ertekin C, Ercan I, Solakoglu S, Karcagi V, Straub V, Bushby K, Lochmuller H, Serdaroglu-Oflazer P. Oculopharyngodistal myopathy is a distinct entity: Clinical and genetic features of 47 patients. Neurology 2011; 76:227-35. [DOI: 10.1212/wnl.0b013e318207b043] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
125
|
Quinlivan R, Shaw N, Bushby K. 170th ENMC International Workshop: Bone protection for corticosteroid treated Duchenne muscular dystrophy. 27–29 November 2009, Naarden, The Netherlands. Neuromuscul Disord 2010; 20:761-9. [DOI: 10.1016/j.nmd.2010.07.272] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2010] [Revised: 07/04/2010] [Accepted: 07/08/2010] [Indexed: 01/06/2023]
|
126
|
Burke G, Hillier C, Cole J, Sampson M, Bridges L, Bushby K, Barresi R, Hammans SR. Calpainopathy presenting as foot drop in a 41 year old. Neuromuscul Disord 2010; 20:407-10. [PMID: 20580976 DOI: 10.1016/j.nmd.2010.04.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2009] [Revised: 04/14/2010] [Accepted: 04/16/2010] [Indexed: 11/25/2022]
Abstract
Mutations in the gene encoding muscle-specific calpain 3 protease cause limb girdle muscular dystrophy type 2A. Calpainopathy is characterised by progressive symmetrical atrophy of pelvic, scapular and trunk muscles with an elevated creatine kinase. Most patients develop symptoms in childhood and lose the ability to walk by the age of 40 years. We describe a man who presented with foot drop at the age of 41 years, together with neurophysiological, histopathological and genetic data. This is the first report of calpainopathy presenting as foot drop, and widens the phenotype associated with this disease.
Collapse
|
127
|
Guglieri M, Herr B, McColl E, Eagle M, Pandya S, McDermott M, Tawil R, Martens W, Annis C, Hirtz D, Kirschner J, Korinthenberg R, Hart K, Brown M, Rafferty K, Griggs R, Bushby K. P3.52 FOR-DMD: double-blind randomized trial to optimize steroid regime in Duchenne Muscular Dystrophy (DMD). Neuromuscul Disord 2010. [DOI: 10.1016/j.nmd.2010.07.194] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
128
|
Shrewsbury S, Cirak S, Guglieri M, Bushby K, Muntoni F. O.16 Current progress and preliminary results with the systemic administration trial of AVI-4658, a novel phosphorodiamidate morpholino oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD). Neuromuscul Disord 2010. [DOI: 10.1016/j.nmd.2010.07.140] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
129
|
Hicks D, Sarkozy A, Muelas N, Huebner A, Hudson G, Barresi R, Miller J, Gowers J, Hughes P, Roberts R, Turnbull D, Krause S, Walter M, Laval S, Straub V, Lochmüller H, Bushby K. P1.24 Mutations in ANO5 represent a common cause of non-dysferlin LGMD2B and Miyoshi myopathy. Neuromuscul Disord 2010. [DOI: 10.1016/j.nmd.2010.07.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
130
|
|
131
|
Willis T, Hollingsworth K, Blamire A, Mayhew A, Eagle M, Bushby K, Lochmüller H, Straub V. P88 MRI in LGMD2I: a qualitative and quantitative analysis using the 3 point Dixon technique. Neuromuscul Disord 2010. [DOI: 10.1016/s0960-8966(10)70103-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
132
|
Sarkozy A, McKenna C, Straub V, Lochmüller H, Goldfarb L, Bushby K. P85 Recurrent BAG3 gene mutation in a British family with two siblings with severe myofibrillar myopathy. Neuromuscul Disord 2010. [DOI: 10.1016/s0960-8966(10)70100-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
133
|
Ritso M, Jørgensen L, Laval S, Straub V, Bushby K, Lochmüller H. P35 Immortalisation and characterisation of muscle stem cells. Neuromuscul Disord 2010. [DOI: 10.1016/s0960-8966(10)70050-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
134
|
Blain A, Greally E, Jørgensen L, Laval S, Bushby K, MacGowan G, Lochmüller H, Straub V. P24 Blocking calcium influx with streptomycin worsens myocardial pathology in the mdx mouse model of muscular dystrophy. Neuromuscul Disord 2010. [DOI: 10.1016/s0960-8966(10)70039-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
135
|
Wood A, Jepson C, Laval S, Bushby K, Lochmüller H, Barresi R, Müller J, Straub V. P15 Modelling the role of dystroglycan glycosylation in angiogenesis using zebrafish. Neuromuscul Disord 2010. [DOI: 10.1016/s0960-8966(10)70030-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
136
|
Choudhury R, Barreto G, Ganeshaguru K, Cirak S, Scoto M, Muntoni F, Guglieri M, Straub V, Bell G, Speed C, Bourke J, Bushby K, Quinlivan R, Jones R, Hunt A. P07 Translation related clinical trials in duchenne muscular dystrophy (DMD) in the UK. Neuromuscul Disord 2010. [DOI: 10.1016/s0960-8966(10)70022-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
137
|
Muntoni F, Sebahattin Cirak S, Guglieri M, Arechavala V, Morgan J, Feng L, Torelli S, Bhardwaj N, Sewry C, Straub V, Shrewsbury S, Bushby K. O04 Results of a systemic antisense study in Duchenne muscular dystrophy. Neuromuscul Disord 2010. [DOI: 10.1016/s0960-8966(10)70005-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
138
|
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010; 9:177-89. [PMID: 19945914 DOI: 10.1016/s1474-4422(09)70272-8] [Citation(s) in RCA: 708] [Impact Index Per Article: 50.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Optimum management of Duchenne muscular dystrophy (DMD) requires a multidisciplinary approach that focuses on anticipatory and preventive measures as well as active interventions to address the primary and secondary aspects of the disorder. Implementing comprehensive management strategies can favourably alter the natural history of the disease and improve function, quality of life, and longevity. Standardised care can also facilitate planning for multicentre trials and help with the identification of areas in which care can be improved. Here, we present a comprehensive set of DMD care recommendations for management of rehabilitation, orthopaedic, respiratory, cardiovascular, gastroenterology/nutrition, and pain issues, as well as general surgical and emergency-room precautions. Together with part 1 of this Review, which focuses on diagnosis, pharmacological treatment, and psychosocial care, these recommendations allow diagnosis and management to occur in a coordinated multidisciplinary fashion.
Collapse
|
139
|
Hicks D, Lampe A, Laval S, Allamand V, Jimenez-Mallebrera C, Walter M, Muntoni F, Quijano-Roy S, Richard P, Straub V, Lochmuller H, Bushby K. Response to letter from Bernardi. Brain 2009. [DOI: 10.1093/brain/awp022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
140
|
Greally E, Davison B, Patel R, Blain A, Laval S, Lochmüller H, Bushby K, Blamire A, G. MacGowan, Straub V. M.P.5.01 Magnetic resonance imaging of cardiac function in mouse models for muscular dystrophy associated cardiomyopathy. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
141
|
Vita G, Kirk R, Lochmüller H, Bushby K, Straub V. G.P.13.10 Early cardiomyopathy in DMD. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.305] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
142
|
Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Abbs S, Nihoyannopoulos P, Garralda M, Rutherford M, McCulley C, Popplewell L, Graham I, Dickson G, Wood M, Wells D, Wilton S, Holt T, Kole R, Straub V, Bushby K, Sewry C, Morgan J, Muntoni F. T.O.3 Restoration of dystrophin expression in Duchenne muscular dystrophy: A single blind, placebo-controlled dose escalation study using morpholino oligomer AVI-4658. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
143
|
Collins J, Hicks D, Sarcozy A, Lampe A, Norwood F, Straub V, Lochmüller H, Bushby K. EM.P.4.05 Bethlem myopathy; new insights on prevalence, phenotypic variability and genetic heterogeneity. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
144
|
Bushby K, Birnkrant D, Case L, Clemens P, Cripe L, Finkel R, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C. G.P.13.05 The diagnosis and management of Duchenne muscular dystrophy: Internationally generated care recommendations. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
145
|
Hornsey M, Chiu Y, Jorgensen L, Klinge L, Laval S, Barresi R, Straub V, Lochmuller H, Bushby K. G.P.6.08 The evaluation of novel therapeutic strategies for the treatment of dysferlinopathy. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
146
|
Sarkozy A, Cheetham T, Pearce S, Rawlings D, Eagle M, Vita G, Guglieri M, Straub V, Bushby K. G.P.13.11 Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne muscular dystrophy. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
147
|
Charlton R, Henderson M, Richards J, Hicks D, Reza M, Straub V, Lochmüller H, Bushby K, Barresi R. EM.P.4.08 Chain-specific antibody testing of collagen VI: An additional pre-screening strategy for the diagnosis of Bethlem myopathy. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
148
|
Blain A, Bauer R, MacGowan G, Greally E, Laval S, Bushby K, Straub V. T.P.2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
149
|
Bushby K, Lynn S, Straub T. Collaborating to bring new therapies to the patient--the TREAT-NMD model. ACTA MYOLOGICA : MYOPATHIES AND CARDIOMYOPATHIES : OFFICIAL JOURNAL OF THE MEDITERRANEAN SOCIETY OF MYOLOGY 2009; 28:12-15. [PMID: 19772190 PMCID: PMC2859629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
|
150
|
Garrood P, Hollingsworth K, Aribisala B, Bushby K, Straub V. G.P.6.02 MRI in Duchenne muscular dystrophy: Tracking progression. Neuromuscul Disord 2008. [DOI: 10.1016/j.nmd.2008.06.172] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|